IL-1 Affibody

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameIL-1 Affibody
Drug Alias NameN/A
ClassificationBiologics > Biosimilar
Mechanisms of ActionInterleukin-1 beta inhibitors
TargetsInterleukin-1 beta
Therapy Area/IndicationsInflammationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAffibody AbSobi
China Registration ClassN/A

Develop Information

Active CompaniesSobiAffibody Ab
Inactive CompaniesN/A
Active IndicationsInflammationAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A